-+ 0.00%
-+ 0.00%
-+ 0.00%

Dr. Reddy's Executive During Earnings Conference Call Says Company Has Launched Generic Semaglutide Tablets In India; Not Practical To Move To U.S. Immediately Amid Tariff Environment; Working To Resume Semaglutide Supplies At Earliest; Hoping To Get Semaglutide To Market By November

Benzinga·07/22/2026 12:33:25
語音播報

https://drreddys.zoom.us/webinar/register/WN_xVkKzh0MSyaxs-eKX8_0wg#/registration